Clinical trialCLINICALTRIALSApr 1
Researchers are looking for 88 people with Fragile X Syndrome or Creatine Transporter Deficiency to test a new imaging technology that can see how the brain works. Both of these are genetic conditions that affect how the brain develops and cause intellectual disability. This study might help doctors better understand and diagnose these conditions in the future.
WHY IT MATTERSThis trial is recruiting patients with two of the most common X-linked intellectual disability disorders and may provide a new diagnostic tool that could improve how these conditions are identified and monitored.
ResearchPUBMEDMar 26
Scientists studied how different mutations in the CHD4 gene affect the heart and blood vessels in patients with rare diseases. CHD4 is a protein that helps control how genes are turned on and off in cells. By using computer analysis, researchers found that mutations in different parts of this protein cause different types of heart and vessel problems, which could help doctors better understand and classify these genetic conditions.
WHY IT MATTERSThis research provides a framework for doctors to predict how specific CHD4 mutations will affect individual patients' hearts and blood vessels, potentially improving diagnosis and treatment planning for rare conditions like Sifrim-Hitz-Weiss syndrome and moyamoya angiopathy.
Clinical trialCLINICALTRIALSMar 26
Researchers are testing a new genetic tool called RNA-Seq to help diagnose rare diseases in children and adults whose current genetic tests came back negative. This tool looks at how genes are turned on and off in cells, which can reveal problems that standard DNA testing misses. The study will first test the tool in healthy people and those with known genetic conditions, then use it to try to diagnose patients with undiagnosed rare diseases.
WHY IT MATTERSIf you have a child or family member with symptoms of a rare kidney or genetic disease but genetic testing hasn't found answers, this trial could offer a new diagnostic pathway that standard tests have missed.